TP53 and cancer: Examining 30 types of human cancers represented in the TCGA dataset, we observed that TP53 mutations and DINO hypermethylation are mutually exclusive cancer alterations in six types of human cancer, including soft tissue sarcoma, skin melanoma, diffuse large B cell lymphoma and stomach adenocarcinoma [17].